Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Total 13F shares
-
18,130,684
-
Share change
-
+633,134
-
Total reported value
-
$127,807,000
-
Price per share
-
$7.04
-
Number of holders
-
34
-
Value change
-
+$4,504,862
-
Number of buys
-
16
-
Number of sells
-
16
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q3 2017
As of 30 Sep 2017,
SINOVAC BIOTECH LTD. - Common Shares (SVA) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,130,684 shares.
The largest 10 holders included
SAIF Advisors Ltd, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, GLG Partners LP, MORGAN STANLEY, DEUTSCHE BANK AG\, Eqis Capital Management, Inc., WOLVERINE ASSET MANAGEMENT LLC, STATE STREET CORP, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
34
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.